Survival of patients with heart failure: a systematic review and meta-analysis protocol

Introduction: Heart failure (HF) is a chronic syndrome that necessitates patients' active management of symptoms and adherence to a complex medication regimen. Identifying and treating symptoms early are crucial components of heart failure care, aiming to enhance quality of life and reduce the risk of hospitalization and mortality. Methods and analysis: This review included observational studies or studies that incorporated both interventional and observational phases. Three independent reviewers will search multiple databases, including PubMed, Web of Science, and Scopus. There was no geographical restriction, and the languages of the studies were written in English. The studies were published from August 2018 to August 2023. Three independent reviewers will carry out the literature screening, research selection, and data extraction. Stata 17.0 software was used to construct a funnel map, assess heterogeneity, perform subgroup analysis, and complete sensitivity analysis. Ethics and dissemination: This systematic review aimed to present the most recent findings regarding the survival rates and prognostic indicators of individuals with HF. By comparing outcomes over time, we seek to gain insights into the influence of evidence-based treatment advancements on the average survival of patients. The outcomes of this review are expected to be advantageous for various stakeholders, such as patient advocacy groups, the medical community, policymakers, and researchers. PROSPERO registration number: CRD42023456390